Muhammad Hammad Ali Mithani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Muhammad Hammad Ali Mithani has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Salman El Khalid
The Kidney Centre, Post Graduate Training Institute, Karachi-Pakistan
3 shared publications Adnan Siddiq Awan
The Kidney Centre Post Graduate Training Institute, Karachi
2 shared publications- Adnan Siddiq Awan
PAF Hospital, Karachi-Pakistan
2 shared publications - Imran Sharif
Department of Urology, Faculty of Surgery, The Kidney Centre PGTI, Karachi-Pakistan
2 shared publications Salman El Khalid
The Kidney Centre Postgraduate Training Institute, Karachi, Pakistan
2 shared publicationsShariq Anis Khan
The Kidney Centre Post Graduate Training Institute, Karachi
2 shared publications
Latest Publications
- Open Access
- 20 August 2026
- Published by Springer Nature in BMC Urology
- Vol. 26 (1)
Comparative efficacy and safety of silodosin (Silorap®) versus tamsulosin (Tamsolin®) for medical expulsive therapy of distal ureteral stones
Purpose: The study objective was to compare the efficacy and safety of Silodosin (Silorap ® ) versus Tamsulosin (Tamsolin ® ) in facilitating the passage of acutely obstructing distal ureteral stones. Methods: This multicenter, randomized, comparative study enrolled 336 adult patients with a single distal ureteric calculus (5–10 mm) across sixteen tertiary care centers in Pakistan. Participants were randomized to receive Silodosin (Silorap ® ) or Tamsulosin (Tamsolin ® ) and followed for 30 days. Primary outcome was stone expulsion rate at four weeks; secondary outcomes included time to expulsion, analgesic use, emergency visits, and safety outcomes. Results: Baseline characteristics were comparable between groups. The stone expulsion rate was significantly higher with Silodosin (112/166; 67.47%) than with Tamsulosin (92/170; 54.12%; p = 0.012). Mean expulsion time was 13.68 ± 8.97 days for Silodosin and 14.33 ± 9.65 days for Tamsulosin (median 12 days; p = 0.701). Kaplan–Meier analysis showed similar time to passage (log-rank p = 0.728). Pain scores declined significantly in both groups. Both treatments were well tolerated; headache and postural hypotension were the most common adverse events, while retrograde ejaculation occurred more frequently with Silodosin. Serious events such as palpitation and syncope were rare and manageable, with no significant differences in vital signs. Conclusion: Silodosin (Silorap ® ) and Tamsulosin (Tamsolin ® ) are effective and well tolerated for medical expulsive therapy in distal ureteral stones. Silodosin achieved a higher stone expulsion rate, though time to expulsion was similar between groups. Trial registration: ClinicalTrials.gov ID NCT05977647; Date of registration: 2023-08-04.
- 20 August 2026
- Published by Springer Nature in BMC Urology
- Vol. 26 (1)
Open AccessComparative efficacy and safety of silodosin (Silorap®) versus tamsulosin (Tamsolin®) for medical expulsive therapy of distal ureteral stones
Purpose: The study objective was to compare the efficacy and safety of Silodosin (Silorap ® ) versus Tamsulosin (Tamsolin ® ) in facilitating the passage of acutely obstructing distal ureteral stones. Methods: This multicenter, randomized, comparative study enrolled 336 adult patients with a single distal ureteric calculus (5–10 mm) across sixteen tertiary care centers in Pakistan. Participants were randomized to receive Silodosin (Silorap ® ) or Tamsulosin (Tamsolin ® ) and followed for 30 days. Primary outcome was stone expulsion rate at four weeks; secondary outcomes included time to expulsion, analgesic use, emergency visits, and safety outcomes. Results: Baseline characteristics were comparable between groups. The stone expulsion rate was significantly higher with Silodosin (112/166; 67.47%) than with Tamsulosin (92/170; 54.12%; p = 0.012). Mean expulsion time was 13.68 ± 8.97 days for Silodosin and 14.33 ± 9.65 days for Tamsulosin (median 12 days; p = 0.701). Kaplan–Meier analysis showed similar time to passage (log-rank p = 0.728). Pain scores declined significantly in both groups. Both treatments were well tolerated; headache and postural hypotension were the most common adverse events, while retrograde ejaculation occurred more frequently with Silodosin. Serious events such as palpitation and syncope were rare and manageable, with no significant differences in vital signs. Conclusion: Silodosin (Silorap ® ) and Tamsulosin (Tamsolin ® ) are effective and well tolerated for medical expulsive therapy in distal ureteral stones. Silodosin achieved a higher stone expulsion rate, though time to expulsion was similar between groups. Trial registration: ClinicalTrials.gov ID NCT05977647; Date of registration: 2023-08-04.
- Open Access
- 26 February 2022
- Published by Advance Educational Institute and Research Center (Publications) in International Journal of Endorsing Health Science Research (IJEHSR)
- Vol. 10 (1) , 72-77
Current practices of urologists regarding intravesical therapy use for non-muscle-invasive bladder cancer patients.
Background: Leading urology guidelines recommend intravesical chemotherapy and immunotherapy for non-muscle invasive bladder cancer (NMIBC) to reduce the risk of recurrence and progression. This study aims to evaluate the self-reported practices regarding intravesical therapy use for patients with non-muscle-invasive bladder cancer among urologists in Karachi. Methodology: In this cross-sectional study, a proforma-based survey was conducted between January and March 2018, in which printed questionnaires regarding adjuvant treatment options for NMIBC were administered and collected by primary investigators among urologists in leading institutions of Karachi. Results: Overall, 80% of respondents reported routine administration of single instillation of intravesical chemotherapy (SICA) after transurethral resection of bladder tumor (TURBT), and almost one-third of them (37.3%) give SICA within 6 hours inward. A quarter of respondents practice induction therapy routinely in low-risk BC using Mitomycin, whereas 76.5% in high-risk cases use Bacillus Calmette Geurin (BCG) as immunotherapy. Regarding the time duration of intravesical therapy installation, most of the urologists reported for 45 mins (49%) followed by 30 mins (29.4%), 2 hrs (17.6%), and 3 hrs (3.9%). Only 39% reported routinely using maintenance therapy with BCG for high-risk BC. As for BCG failure, 76.5% of participants reported radical cystectomy. Conclusion: Our survey results provide evidence of variation in practices among urologists and poor guideline adherence with the risk of under-treatment of patients with NMIBC. This requires joint efforts of all those involved in the treatment of non-muscle invasive bladder cancer to improve the quality of care.
- 26 February 2022
- Published by Advance Educational Institute and Research Center (Publications) in International Journal of Endorsing Health Science Research (IJEHSR)
- Vol. 10 (1) , 72-77
Open AccessCurrent practices of urologists regarding intravesical therapy use for non-muscle-invasive bladder cancer patients.
Background: Leading urology guidelines recommend intravesical chemotherapy and immunotherapy for non-muscle invasive bladder cancer (NMIBC) to reduce the risk of recurrence and progression. This study aims to evaluate the self-reported practices regarding intravesical therapy use for patients with non-muscle-invasive bladder cancer among urologists in Karachi. Methodology: In this cross-sectional study, a proforma-based survey was conducted between January and March 2018, in which printed questionnaires regarding adjuvant treatment options for NMIBC were administered and collected by primary investigators among urologists in leading institutions of Karachi. Results: Overall, 80% of respondents reported routine administration of single instillation of intravesical chemotherapy (SICA) after transurethral resection of bladder tumor (TURBT), and almost one-third of them (37.3%) give SICA within 6 hours inward. A quarter of respondents practice induction therapy routinely in low-risk BC using Mitomycin, whereas 76.5% in high-risk cases use Bacillus Calmette Geurin (BCG) as immunotherapy. Regarding the time duration of intravesical therapy installation, most of the urologists reported for 45 mins (49%) followed by 30 mins (29.4%), 2 hrs (17.6%), and 3 hrs (3.9%). Only 39% reported routinely using maintenance therapy with BCG for high-risk BC. As for BCG failure, 76.5% of participants reported radical cystectomy. Conclusion: Our survey results provide evidence of variation in practices among urologists and poor guideline adherence with the risk of under-treatment of patients with NMIBC. This requires joint efforts of all those involved in the treatment of non-muscle invasive bladder cancer to improve the quality of care.
- Open Access
- 5 January 2022
- Published by Springer Nature in Cureus
- Vol. 14 (1) , e20964
A Review of the First 100 Cases of Laparoscopic Nephrectomy: A Single-Center Experience
Since 1990, when the first laparoscopic nephrectomy was performed, there has been a dramatic increase in interest in laparoscopic procedures in urological surgeries. The aim of the study was to present our experience with the first 100 cases of laparoscopic nephrectomy at our institute, identify the difficulties encountered, and discuss how to approach the solutions. The data of all patients who underwent laparoscopic nephrectomy between May 2017 and April 2019 (n=100) were reviewed retrospectively. A total of 100 patients (49 men and 51 women), with a mean age of 34.1 ± 15.1 years, underwent laparoscopic nephrectomy. The mean operative time was 108 min (IQR, 45-240). The operative time was significantly reduced with the surgeons' experience. Of 100 cases, only four were converted to open surgery because of bleeding from the renal bed area, strong adhesions from previous surgeries, or morbid obesity. Of 100 patients, 30 were allowed intake on the same operative day while 70 were allowed on the first postoperative day. Intravenous and oral analgesics were discontinued on the second postoperative day in 81 patients. The learning curve in our series of cases is comparable to a very similar study with reduced operative time, reduced blood loss, and fewer complications when compared to open nephrectomy. In addition, setups with minimal previous laparoscopic units can initiate laparoscopic procedures with minimal risk to the patient.
- 5 January 2022
- Published by Springer Nature in Cureus
- Vol. 14 (1) , e20964
Open AccessA Review of the First 100 Cases of Laparoscopic Nephrectomy: A Single-Center Experience
Since 1990, when the first laparoscopic nephrectomy was performed, there has been a dramatic increase in interest in laparoscopic procedures in urological surgeries. The aim of the study was to present our experience with the first 100 cases of laparoscopic nephrectomy at our institute, identify the difficulties encountered, and discuss how to approach the solutions. The data of all patients who underwent laparoscopic nephrectomy between May 2017 and April 2019 (n=100) were reviewed retrospectively. A total of 100 patients (49 men and 51 women), with a mean age of 34.1 ± 15.1 years, underwent laparoscopic nephrectomy. The mean operative time was 108 min (IQR, 45-240). The operative time was significantly reduced with the surgeons' experience. Of 100 cases, only four were converted to open surgery because of bleeding from the renal bed area, strong adhesions from previous surgeries, or morbid obesity. Of 100 patients, 30 were allowed intake on the same operative day while 70 were allowed on the first postoperative day. Intravenous and oral analgesics were discontinued on the second postoperative day in 81 patients. The learning curve in our series of cases is comparable to a very similar study with reduced operative time, reduced blood loss, and fewer complications when compared to open nephrectomy. In addition, setups with minimal previous laparoscopic units can initiate laparoscopic procedures with minimal risk to the patient.
- Open Access
- 1 September 2021
- Published by Advance Educational Institute and Research Center (Publications) in International Journal of Endorsing Health Science Research (IJEHSR)
- Vol. 9 (3) , 371-377
Guy’s Stone Score: A Predictive Tool for Outcomes of Percutaneous Nephrolithotomy
Background: Predicting stone clearance before intervention can be useful to plan the modality of treatment and calculate the cost of procedures. Therefore, this study aims to determine the frequency of successful stone clearance in a patient undergoing percutaneous nephrolithotomy (PCNL) with different categories of Guy's Stone Score (GSS). Methodology: A total of 115 patients undergoing standard PCNL from January to December 2018 were included in this study. According to GSS I-IV, patients were then categorized into four groups after having pre-operative Computed Tomography of Kidney, Ureter, and Bladder (KUB). All the patients received standard general anesthesia and underwent standard PCNL in a prone position. The Percutaneous nephrostomy 18-gauge needle is passed into the pelvis of the kidney, Pelvi-calyceal system opacified and confirmed using fluoroscopy, a guidewire is passed, and 30 Fr Amplatz sheath is introduced after serial dilatation. A 26 Fr nephroscope is then inserted through the working sheath, and the stone is fragmented and removed. Finally, a nephrostomy drain tube is kept at the puncture site. The outcome was accessed in terms of stone clearance rate after PCNL on the 2nd postoperative day using the radiological modality of CT-KUB. Results: Among the 115 patients here were 48(41.7%) categorized as GSS I, 26(22.6%) categorized as GSSII, 20(17.4%) categorized as GSS III, and 21(18.3%) categorized as GSS IV. The overall stone clearance observed was 64.3%, individual stone clearance was GSS I=91.66%, GSS II=53.84%, GSS III=50%, and GSS IV=28.57%. Stone clearance among the different GSS categories was significantly different (pConclusion: The Guy's Stone Score, based on CT scan findings, is a significant system in predicting successful stone-free rates. It is a convenient, quick, and efficient tool for pre-operative assessment, and it can be incorporated as a mandatory protocol before planning PCNL.
- 1 September 2021
- Published by Advance Educational Institute and Research Center (Publications) in International Journal of Endorsing Health Science Research (IJEHSR)
- Vol. 9 (3) , 371-377
Open AccessGuy’s Stone Score: A Predictive Tool for Outcomes of Percutaneous Nephrolithotomy
Background: Predicting stone clearance before intervention can be useful to plan the modality of treatment and calculate the cost of procedures. Therefore, this study aims to determine the frequency of successful stone clearance in a patient undergoing percutaneous nephrolithotomy (PCNL) with different categories of Guy's Stone Score (GSS). Methodology: A total of 115 patients undergoing standard PCNL from January to December 2018 were included in this study. According to GSS I-IV, patients were then categorized into four groups after having pre-operative Computed Tomography of Kidney, Ureter, and Bladder (KUB). All the patients received standard general anesthesia and underwent standard PCNL in a prone position. The Percutaneous nephrostomy 18-gauge needle is passed into the pelvis of the kidney, Pelvi-calyceal system opacified and confirmed using fluoroscopy, a guidewire is passed, and 30 Fr Amplatz sheath is introduced after serial dilatation. A 26 Fr nephroscope is then inserted through the working sheath, and the stone is fragmented and removed. Finally, a nephrostomy drain tube is kept at the puncture site. The outcome was accessed in terms of stone clearance rate after PCNL on the 2nd postoperative day using the radiological modality of CT-KUB. Results: Among the 115 patients here were 48(41.7%) categorized as GSS I, 26(22.6%) categorized as GSSII, 20(17.4%) categorized as GSS III, and 21(18.3%) categorized as GSS IV. The overall stone clearance observed was 64.3%, individual stone clearance was GSS I=91.66%, GSS II=53.84%, GSS III=50%, and GSS IV=28.57%. Stone clearance among the different GSS categories was significantly different (pConclusion: The Guy's Stone Score, based on CT scan findings, is a significant system in predicting successful stone-free rates. It is a convenient, quick, and efficient tool for pre-operative assessment, and it can be incorporated as a mandatory protocol before planning PCNL.
- 1 December 2018
- Published by Galenos Yayinevi in Journal of Urological Surgery
- Vol. 5 (4) , 157-164
Is Routine Measurement of Post-operative Hemoglobin and Electrolytes Necessary in Every Patient After Transurethral Resection of the Prostate?
- 1 December 2018
- Published by Galenos Yayinevi in Journal of Urological Surgery
- Vol. 5 (4) , 157-164
Is Routine Measurement of Post-operative Hemoglobin and Electrolytes Necessary in Every Patient After Transurethral Resection of the Prostate?
- 1 January 2018
- Vol. 68 (1) , 55-58
Awareness of risk factors and fallacies associated with urinary bladder cancer in our population: A prospective survey
Objective: To determine the awareness of risk factors for bladder cancer and false beliefs associated with this disease. Methods: This cross-sectional study was conducted at the Kidney Centre, Karachi, from January to February 2015, and comprised subjects who presented to the various in-house clinics. The subjects were interviewed using a questionnaire comprising demographic parameters, level of education and awareness of smoking hazards, knowledge and false beliefs associated with bladder cancer. A pilot study was performed prior to the main study and the questionnaire was redesigned accordingly. SPSS 20 was used for data analysis. Results: Of the 1,000 respondents, 593(59.3%) were males and 407(40.7%) were females. Moreover, 229(22.9%) respondents were aware of the association between smoking and bladder cancer compared to 858(85.8%) who knew that there is an association between smoking and lung cancer. Besides, 479(47.9%) respondents said that smoking caused tuberculosis. Patients with a higher level of education were statistically more likely to be aware of the association between smoking and bladder cancer, i.e. 91(9.1%) uneducated, 208(20.8%) primary, 182(18.2%) secondary, 222(22.2%) intermediate and 352(35.2%) graduates (p=0.0001). Most common fallacy associated with bladder cancer was low intake of water 504(50.4%), followed by multiple sexual partners 362(36.2%). Conclusion: Most patients were unaware of the relationship between bladder cancer and tobacco smoking.
- 1 January 2018
- Vol. 68 (1) , 55-58
Awareness of risk factors and fallacies associated with urinary bladder cancer in our population: A prospective survey
Objective: To determine the awareness of risk factors for bladder cancer and false beliefs associated with this disease. Methods: This cross-sectional study was conducted at the Kidney Centre, Karachi, from January to February 2015, and comprised subjects who presented to the various in-house clinics. The subjects were interviewed using a questionnaire comprising demographic parameters, level of education and awareness of smoking hazards, knowledge and false beliefs associated with bladder cancer. A pilot study was performed prior to the main study and the questionnaire was redesigned accordingly. SPSS 20 was used for data analysis. Results: Of the 1,000 respondents, 593(59.3%) were males and 407(40.7%) were females. Moreover, 229(22.9%) respondents were aware of the association between smoking and bladder cancer compared to 858(85.8%) who knew that there is an association between smoking and lung cancer. Besides, 479(47.9%) respondents said that smoking caused tuberculosis. Patients with a higher level of education were statistically more likely to be aware of the association between smoking and bladder cancer, i.e. 91(9.1%) uneducated, 208(20.8%) primary, 182(18.2%) secondary, 222(22.2%) intermediate and 352(35.2%) graduates (p=0.0001). Most common fallacy associated with bladder cancer was low intake of water 504(50.4%), followed by multiple sexual partners 362(36.2%). Conclusion: Most patients were unaware of the relationship between bladder cancer and tobacco smoking.
- Open Access
- 1 January 2018
- Published by The Korean Urological Association in Investigative and Clinical Urology
- Vol. 59 (6) , 392-398
Outcome of 980 nm diode laser vaporization for benign prostatic hyperplasia: A prospective study
Mithani MH, et al. Investig Clin Urol. 2018 Nov;59(6):392-398. https://doi.org/10.4111/icu.2018.59.6.392
- 1 January 2018
- Published by The Korean Urological Association in Investigative and Clinical Urology
- Vol. 59 (6) , 392-398
Open AccessOutcome of 980 nm diode laser vaporization for benign prostatic hyperplasia: A prospective study
Mithani MH, et al. Investig Clin Urol. 2018 Nov;59(6):392-398. https://doi.org/10.4111/icu.2018.59.6.392